357 related articles for article (PubMed ID: 30704457)
1. Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice.
Yang X; Lu F; Li L; Li J; Luo J; Zhang S; Liu X; Chen G
BMC Complement Altern Med; 2019 Jan; 19(1):35. PubMed ID: 30704457
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction.
Sokolova M; Sahraoui A; Høyem M; Øgaard J; Lien E; Aukrust P; Yndestad A; Ranheim T; Scholz H
Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E912-E923. PubMed ID: 30016155
[TBL] [Abstract][Full Text] [Related]
3. Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-κB pathway and NLRP3 inflammasome.
Liu B; Lu R; Li H; Zhou Y; Zhang P; Bai L; Chen D; Chen J; Li J; Yu P; Wu J; Liang C; Song J; Liu X; Zhou J
Phytomedicine; 2019 Jun; 59():152913. PubMed ID: 30991182
[TBL] [Abstract][Full Text] [Related]
4. Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome.
Chen F; Wei G; Xu J; Ma X; Wang Q
BMC Complement Altern Med; 2018 Jun; 18(1):192. PubMed ID: 29929501
[TBL] [Abstract][Full Text] [Related]
5. The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation.
Kulak K; Westermark GT; Papac-Milicevic N; Renström E; Blom AM; King BC
Diabetologia; 2017 Aug; 60(8):1522-1533. PubMed ID: 28500395
[TBL] [Abstract][Full Text] [Related]
6. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice.
Yu Y; Chen D; Zhao Y; Zhu J; Dong X
Int J Immunopathol Pharmacol; 2021; 35():20587384211036819. PubMed ID: 34399601
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice.
Zhai Y; Meng X; Ye T; Xie W; Sun G; Sun X
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495433
[TBL] [Abstract][Full Text] [Related]
8. IAPP/amylin deposition, which is correlated with expressions of ASC and IL-1β in β-cells of Langerhans' islets, directly initiates NLRP3 inflammasome activation.
Morikawa S; Kaneko N; Okumura C; Taguchi H; Kurata M; Yamamoto T; Osawa H; Nakanishi A; Zako T; Masumoto J
Int J Immunopathol Pharmacol; 2018; 32():2058738418788749. PubMed ID: 30014749
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the Inflammasome NLRP3 by Arglabin Attenuates Inflammation, Protects Pancreatic β-Cells from Apoptosis, and Prevents Type 2 Diabetes Mellitus Development in ApoE2Ki Mice on a Chronic High-Fat Diet.
Abderrazak A; El Hadri K; Bosc E; Blondeau B; Slimane MN; Büchele B; Simmet T; Couchie D; Rouis M
J Pharmacol Exp Ther; 2016 Jun; 357(3):487-94. PubMed ID: 27044804
[TBL] [Abstract][Full Text] [Related]
10. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
Yin Y; Chen F; Wang W; Wang H; Zhang X
Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
[TBL] [Abstract][Full Text] [Related]
13. Empagliflozin protects diabetic pancreatic tissue from damage by inhibiting the activation of the NLRP3/caspase-1/GSDMD pathway in pancreatic β cells: in vitro and in vivo studies.
Liu P; Zhang Z; Wang J; Zhang X; Yu X; Li Y
Bioengineered; 2021 Dec; 12(2):9356-9366. PubMed ID: 34823419
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.
Wang Y; Yu B; Wang L; Yang M; Xia Z; Wei W; Zhang F; Yuan X
PLoS One; 2017; 12(7):e0181248. PubMed ID: 28708885
[TBL] [Abstract][Full Text] [Related]
15. Jia-Wei-Si-Miao-Wan alleviates acute gouty arthritis by targeting NLRP3 inflammasome.
Yuan X; Fan YS; Xu L; Xie GQ; Feng XH; Qian K
J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):63-71. PubMed ID: 30697988
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate inhibits inflammation and improves wound healing by downregulating the NLR family pyrin domain containing 3 (NLRP3) inflammasome in diabetic rats.
Wang T; Zhao J; Zhang J; Mei J; Shao M; Pan Y; Yang W; Jiang Y; Liu F; Jia W
J Diabetes; 2018 Jul; 10(7):556-563. PubMed ID: 29171721
[TBL] [Abstract][Full Text] [Related]
17. Evidence against a role for NLRP3-driven islet inflammation in db/db mice.
Kammoun HL; Allen TL; Henstridge DC; Barre S; Coll RC; Lancaster GI; Cron L; Reibe S; Chan JY; Bensellam M; Laybutt DR; Butler MS; Robertson AAB; O'Neill LA; Cooper MA; Febbraio MA
Mol Metab; 2018 Apr; 10():66-73. PubMed ID: 29478918
[TBL] [Abstract][Full Text] [Related]
18. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
20. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]